Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models
Crossref DOI link: https://doi.org/10.1007/s13277-015-3725-3
Published Online: 2015-07-29
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gravina, Giovanni Luca
Mancini, Andrea
Scarsella, Luca
Colapietro, Alessandro
Jitariuc, Ana
Vitale, Flora
Marampon, Francesco
Ricevuto, Enrico
Festuccia, Claudio
Text and Data Mining valid from 2015-07-29